Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine

Clin Pharmacol Ther. 1993 Jul;54(1):23-7. doi: 10.1038/clpt.1993.104.


We studied the short-term effect of oral doses of quinine and quinidine on the renal clearance of amantadine in healthy young (age range, 27 to 39 years) and older (age range, 60 to 72 years) adults of both genders in a three-limbed randomized crossover study. Renal clearance of amantadine (13.2 +/- 5.8 L/hr) was significantly inhibited by quinine (9.7 +/- 4.8 L/hr) and quinidine (8.9 +/- 4.0 L/hr) only in male subjects and was not associated with age. The chiral selectivity for the renal clearance of quinidine over quinine was confirmed and extended with the suggestion of both age- and gender-associated changes on the renal clearance ratio for these two diastereomeric drugs. These data support the continued use of amantadine for studies on the renal elimination of organic cationic drugs.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aging / metabolism
  • Amantadine / pharmacokinetics*
  • Analysis of Variance
  • Drug Interactions
  • Female
  • Humans
  • Kidney / drug effects*
  • Kidney / metabolism
  • Male
  • Middle Aged
  • Quinidine / pharmacology*
  • Quinine / pharmacology*
  • Reference Values
  • Sex Characteristics


  • Quinine
  • Amantadine
  • Quinidine